Literature DB >> 35029089

Efficient gene editing in a medaka (Oryzias latipes) cell line and embryos by SpCas9/tRNA-gRNA.

Qihua Pan1,2, Junzhi Luo2, Yuewen Jiang2, Zhi Wang2, Ke Lu2, Tiansheng Chen3,4.   

Abstract

Generation of mutants with clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) is commonly carried out in fish species by co-injecting a mixture of Cas9 messenger RNA (mRNA) or protein and transcribed guide RNA (gRNA). However, the appropriate expression system to produce functional gRNAs in fish embryos and cells is rarely present. In this study, we employed a poly-transfer RNA (tRNA)-gRNA (PTG) system driven by cytomegalovirus (CMV) promoter to target the medaka (Oryzias latipes) endogenous gene tyrosinase(tyr) or paired box 6.1 (pax6.1) and illustrated its function in a medaka cell line and embryos. The PTG system was combined with the CRISPR/Cas9 system under high levels of promoter to successfully induce gene editing in medaka. This is a valuable step forward in potential application of the CRISPR/Cas9 system in medaka and other teleosts.

Entities:  

Keywords:  Embryos; Fish cells; Gene editing; Medaka (Oryzias latipes); Poly-tRNA-gRNA

Mesh:

Substances:

Year:  2022        PMID: 35029089      PMCID: PMC8758932          DOI: 10.1631/jzus.B2100343

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  40 in total

1.  Self-cleaving ribozymes enable the production of guide RNAs from unlimited choices of promoters for CRISPR/Cas9 mediated genome editing.

Authors:  Yubing He; Tao Zhang; Ning Yang; Meilian Xu; Lang Yan; Lihao Wang; Rongchen Wang; Yunde Zhao
Journal:  J Genet Genomics       Date:  2017-08-24       Impact factor: 4.275

2.  Polycistronic tRNA and CRISPR guide-RNA enables highly efficient multiplexed genome engineering in human cells.

Authors:  Fengping Dong; Kabin Xie; Yueying Chen; Yinong Yang; Yingwei Mao
Journal:  Biochem Biophys Res Commun       Date:  2016-11-25       Impact factor: 3.575

Review 3.  Gene editing: an instrument for practical application of gene biology to plant breeding.

Authors:  Yuan-Yuan Tan; Hao Du; Xia Wu; Yan-Hua Liu; Meng Jiang; Shi-Yong Song; Liang Wu; Qing-Yao Shu
Journal:  J Zhejiang Univ Sci B       Date:  2020-06       Impact factor: 3.066

4.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

5.  Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells.

Authors:  Lior Nissim; Samuel D Perli; Alexandra Fridkin; Pablo Perez-Pinera; Timothy K Lu
Journal:  Mol Cell       Date:  2014-05-15       Impact factor: 17.970

6.  A novel nucleo-cytoplasmic hybrid clone formed via androgenesis in polyploid gibel carp.

Authors:  Zhong-Wei Wang; Hua-Ping Zhu; Da Wang; Fang-Fang Jiang; Wei Guo; Li Zhou; Jian-Fang Gui
Journal:  BMC Res Notes       Date:  2011-03-28

7.  A Convenient Cas9-based Conditional Knockout Strategy for Simultaneously Targeting Multiple Genes in Mouse.

Authors:  Jiang Chen; Yinan Du; Xueyan He; Xingxu Huang; Yun S Shi
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

8.  Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA.

Authors:  Li Xu; Lixia Zhao; Yandi Gao; Jing Xu; Renzhi Han
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

9.  CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.

Authors:  Chao Li; Eleanor Brant; Hikmet Budak; Baohong Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2021-04-15       Impact factor: 3.066

10.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.